CN Stock MarketDetailed Quotes
000504 Landfar Bio-medicine
- 10.15
- 0.000.00%
Trading Nov 8 09:56 CST
3.35BMarket Cap-90625P/E (TTM)
10.33High10.07Low21.88KlotVolume10.19Open10.15Pre Close22.25MTurnover0.70%Turnover RatioLossP/E (Static)330.02MShares12.3752wk High13.48P/B3.15BFloat Cap5.2652wk Low11.17Limit Up310.67MShs Float36.97Historical High9.14Limit Down2.56%Amplitude1.37Historical Low--Dividend TTM10.17Avg Price10.37KlotAsk--Div YieldTTM100Lot Size10.75KlotBid
Landfar Bio-medicine Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -14.15%121.6M | -22.56%75.43M | -20.16%38.31M | -20.57%199.8M | -18.03%141.64M | -14.52%97.41M | -24.71%47.98M | -6.45%251.53M | 27.56%172.79M | 31.22%113.96M |
| Refunds of taxes and levies | -66.75%174.64K | ---- | ---- | -85.52%583.82K | -81.15%525.25K | -80.05%525.25K | ---- | --4.03M | 24,192.32%2.79M | 22,842.35%2.63M |
| Cash received relating to other operating activities | 4.37%13.69M | -63.54%3.83M | -75.11%1.94M | -93.67%6.96M | -90.27%13.12M | -91.89%10.5M | -65.81%7.81M | -36.70%109.9M | 1,520.41%134.88M | 849.36%129.48M |
| Cash inflows from operating activities | -12.76%135.46M | -26.91%79.26M | -27.85%40.26M | -43.27%207.34M | -49.98%155.28M | -55.93%108.43M | -35.57%55.8M | -17.41%365.46M | 115.91%310.46M | 144.86%246.07M |
| Goods services cash paid | 20.99%32.11M | -22.88%17.32M | -31.52%6.85M | -39.92%36.3M | -25.75%26.54M | -12.60%22.46M | -24.91%10M | -68.99%60.42M | 143.87%35.74M | 52.46%25.7M |
| Staff behalf paid | -9.85%53.4M | -9.06%37.15M | -5.55%20.22M | -5.01%78.83M | -4.60%59.24M | -0.99%40.85M | 0.72%21.41M | 16.03%82.99M | 20.59%62.1M | 22.81%41.26M |
| All taxes paid | -44.44%8.91M | -47.62%6.32M | -52.06%2.89M | 41.86%18.83M | 57.11%16.03M | 89.42%12.06M | 38.87%6.04M | -17.33%13.28M | -31.47%10.2M | -49.04%6.37M |
| Cash paid relating to other operating activities | 3.27%34.13M | -30.30%16.62M | -34.92%11.8M | -12.50%37.09M | -54.21%33.05M | -61.17%23.85M | -58.66%18.13M | -19.92%42.39M | 108.06%72.16M | 35.54%61.42M |
| Cash outflows from operating activities | -4.68%128.55M | -21.98%77.41M | -24.86%41.76M | -14.07%171.06M | -25.17%134.85M | -26.37%99.22M | -32.87%55.58M | -40.64%199.08M | 55.72%180.2M | 24.47%134.74M |
| Net cash flows from operating activities | -66.13%6.92M | -79.91%1.85M | -779.35%-1.5M | -78.20%36.28M | -84.32%20.42M | -91.72%9.22M | -94.20%221.5K | 55.35%166.38M | 364.07%130.25M | 1,533.93%111.32M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | -45.80%218.15M | -35.29%203.2M | -3.77%111.15M | 29.67%322.85M | 192.75%402.5M | 258.90%314M | 126.47%115.5M | 98.71%248.98M | 34.40%137.49M | 87.75%87.49M |
| Cash received from returns on investments | 597.18%4.88M | 430.69%3.18M | 571.18%1.42M | ---- | 163.55%699.93K | 311.29%599.31K | 329.93%211.16K | ---- | 39.28%265.58K | -88.30%145.72K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | 5,253.88%17.72M | 6,692.89%20.94M | -99.48%1.4K | ---- | 346.38%330.98K | 10,843.97%308.34K | 32,931.56%270K |
| Cash inflows from investing activities | -47.42%223.03M | -34.40%206.38M | -2.72%112.57M | 36.60%340.57M | 207.21%424.14M | 257.88%314.6M | 126.67%115.71M | 96.13%249.32M | 32.43%138.06M | 77.46%87.91M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | 97.10%16.05M | 67.31%3.41M | 207.51%3.29M | -65.07%5.92M | -31.94%8.14M | -78.75%2.04M | -85.85%1.07M | -46.99%16.94M | -38.20%11.97M | -19.55%9.58M |
| Cash paid to acquire investments | -21.41%317.1M | -3.15%304.1M | 83.21%228.1M | 29.54%321.9M | 174.51%403.5M | 247.00%314M | 88.64%124.5M | 98.32%248.49M | 39.58%146.99M | 117.52%90.49M |
| Net cash paid to acquire subsidiaries and other business units | ---4.6M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -20.19%328.55M | -2.70%307.51M | 84.27%231.39M | 23.50%327.82M | 158.97%411.64M | 215.80%316.04M | 70.71%125.57M | 68.78%265.43M | 27.50%158.96M | 87.01%100.07M |
| Net cash flows from investing activities | -944.12%-105.52M | -6,943.93%-101.12M | -1,105.30%-118.82M | 179.13%12.75M | 159.83%12.5M | 88.20%-1.44M | 56.20%-9.86M | 46.54%-16.12M | -2.32%-20.89M | -206.04%-12.17M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | --273.7M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | ---- | --1.1M | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from borrowing | -35.71%18M | -55.56%8M | 0.00%8M | -62.74%28M | -56.95%28M | -48.78%18M | -63.87%8M | 34.52%75.14M | 35.50%65.04M | -7.53%35.14M |
| Cash inflows from financing activities | -35.71%18M | -55.56%8M | 0.00%8M | 301.53%301.7M | -56.95%28M | -48.78%18M | -63.87%8M | 33.09%75.14M | 34.24%65.04M | -8.61%35.14M |
| Borrowing repayment | -32.12%36M | 56.52%36M | -20.00%8M | 40.00%63M | 51.53%53.04M | -8.00%23M | --10M | 25.00%45M | 118.75%35M | 733.33%25M |
| Dividend interest payment | -12.75%4.81M | 151.60%4.81M | 585.74%4.68M | 33.51%3.21M | 235.80%5.51M | 70.45%1.91M | 38.97%682.93K | 13.37%2.4M | -78.34%1.64M | -86.20%1.12M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | ---- | ---- | --917.33K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash payments relating to other financing activities | 6,846.12%157.67M | 10,284.57%157.2M | 20,513.47%156.17M | -92.15%8.87M | -97.77%2.27M | -98.50%1.51M | --757.63K | 1,110.50%112.89M | 79,333.38%101.94M | --101.13M |
| Cash outflows from financing activities | 226.36%198.47M | 649.33%198M | 1,375.95%168.86M | -53.17%75.07M | -56.12%60.81M | -79.23%26.42M | 2,228.04%11.44M | 237.85%160.29M | 484.72%138.58M | 1,044.63%127.25M |
| Net cash flows from financing activities | -449.99%-180.47M | -2,155.59%-190M | -4,575.33%-160.86M | 366.16%226.63M | 55.38%-32.81M | 90.85%-8.42M | -115.89%-3.44M | -1,044.47%-85.15M | -397.13%-73.54M | -436.99%-92.11M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -83.12%16.93 | -83.12%16.93 | ---- | -79.95%45.35 | -22.19%100.3 | -22.19%100.3 | ---- | 294.73%226.14 | 618.13%128.91 | 618.13%128.91 |
| Net increase in cash and cash equivalents | -249,683.07%-279.07M | -45,043.04%-289.27M | -2,050.16%-281.18M | 323.36%275.66M | -99.69%111.82K | -109.09%-640.79K | -541.76%-13.08M | -24.26%65.11M | 10.56%35.82M | -54.81%7.05M |
| Add:Begin period cash and cash equivalents | 126.38%493.78M | 126.38%493.78M | 126.38%493.78M | 42.56%218.12M | 42.56%218.12M | 42.56%218.12M | 42.56%218.12M | 128.24%153M | 128.24%153M | 128.24%153M |
| End period cash equivalent | -1.61%214.71M | -5.96%204.51M | 3.69%212.6M | 126.38%493.78M | 15.57%218.23M | 35.88%217.48M | 31.47%205.04M | 42.56%218.12M | 89.89%188.83M | 93.69%160.05M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
% Chg
No Data